The TeGenero incident and the Duff Report conclusions: a series of unfortunate events or an avoidable event?
about
Preclinical development of monoclonal antibodies: considerations for the use of non-human primatesTGN1412: From Discovery to DisasterPharmacokinetics and toxicology of therapeutic proteins: Advances and challenges.Application of population pharmacokinetics for preclinical safety and efficacy studies.Pharmacokinetics and pharmacodynamics of rilotumumab: a decade of experience in preclinical and clinical cancer research.Role of receptor occupancy assays by flow cytometry in drug development.Validation of Alternative In Vitro Methods to Animal Testing: Concepts, Challenges, Processes and Tools.Immuno-Oncology: The Third Paradigm in Early Drug Development.Do we need a special ethics for research?Regulatory Affairs introduction.Commentary on the EMA Guideline on strategies to identify and mitigate risks for first-in-human and early clinical trials with investigational medicinal products (EMEA/CHMP/SWP/28367/07 Rev. 1.Revisiting CD28 Superagonist TGN1412 as Potential Therapeutic for Pediatric B Cell Leukemia: A Review.Rationale for Combining Bispecific T Cell Activating Antibodies With Checkpoint Blockade for Cancer Therapy
P2860
Q24655266-6AA301D8-E068-4A1C-90DB-7792D92DD2E3Q28972456-4C6FA8F4-4317-4B5F-9BA0-D40448399EF9Q35929084-C43805C3-B604-4C20-A777-97806F4018BDQ38128345-B8129D81-C29B-4598-B2D2-BCD8C3FA5666Q38442573-0EDC6511-0070-4CB8-BF8E-2E62306B4726Q38679593-C1AD0B34-17A2-41BA-9DEC-EF68414E2EF8Q38965128-FC969F7A-90E3-4493-997B-166E616711CCQ39044147-BEB52D76-F7B5-401C-AB75-EE5E930797EFQ39925740-5254CE22-05F9-4145-AF5A-29996163CAD1Q47975944-6E72A0F2-2325-4EE5-808A-8E0B55DDFBB0Q49937107-B3682C1D-973B-49F0-B3CF-5E10AC3DB43EQ55424862-79BF9C30-003E-48AD-8AFA-BC159169AC25Q56890857-DAC62C62-5F5F-4D71-A400-7B6E4E5319B8
P2860
The TeGenero incident and the Duff Report conclusions: a series of unfortunate events or an avoidable event?
description
2009 nî lūn-bûn
@nan
2009 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
The TeGenero incident and the ...... events or an avoidable event?
@ast
The TeGenero incident and the ...... events or an avoidable event?
@en
The TeGenero incident and the ...... events or an avoidable event?
@nl
type
label
The TeGenero incident and the ...... events or an avoidable event?
@ast
The TeGenero incident and the ...... events or an avoidable event?
@en
The TeGenero incident and the ...... events or an avoidable event?
@nl
prefLabel
The TeGenero incident and the ...... events or an avoidable event?
@ast
The TeGenero incident and the ...... events or an avoidable event?
@en
The TeGenero incident and the ...... events or an avoidable event?
@nl
P2860
P356
P1476
The TeGenero incident and the ...... events or an avoidable event?
@en
P2093
Christopher J Horvath
Mark N Milton
P2860
P304
P356
10.1177/0192623309332986
P407
P577
2009-02-24T00:00:00Z